Ameritas Investment Company’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Ameritas Investment Company’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-102	Closed	-$6.04K	–	1347
2021 Q1	$6.04K	Buy	+102	New	+$6.15K	﹤0.01%	1661
2020 Q2	–	Sell	-1,611	Closed	-$72K	–	924
2020 Q1	$72K	Buy	1,611 +141	+10%	+$7.11K	0.01%	576
2019 Q4	$78K	Buy	1,470 +264	+22%	+$13K	0.02%	509
2019 Q3	$56K	Buy	+1,206	New	+$57.8K	0.01%	630
2019 Q2	–	Sell	-81	Closed	-$4K	–	518
2019 Q1	$4K	Buy	+81	New	+$4.03K	﹤0.01%	783

Other funds holding IHE

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Ameritas Investment Company's IHE Position: Q2 2021 in Review

Ameritas Investment Company sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2021, closing a stake of 102 shares — an estimated $6.04K sold.

Ameritas Investment Company first reported a position in IHE in Q1 2019 and held it in 5 quarters. The position peaked at $78K in Q4 2019. 101 funds tracked by Wall St. Rank hold IHE as of Q2 2021.

Ameritas Investment Company reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 102 iShares US Pharmaceuticals ETF shares in Q2 2021, an estimated $6.04K.
Ameritas Investment Company first reported a position in iShares US Pharmaceuticals ETF in Q1 2019 and held it in 5 quarters.
Ameritas Investment Company's iShares US Pharmaceuticals ETF position peaked at $78K in Q4 2019.
101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.